J. Sundin

发表

Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome

L. Öhman, V. Théodorou, H. Törnblom, 2019, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects

J. Doré, J. Tap, L. Öhman, 2018, Scientific Reports.

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome

L. Öhman, L. Engstrand, H. Törnblom, 2020, Scientific Reports.

Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double‐blind, placebo‐controlled study

L. Öhman, H. Törnblom, M. Simrén, 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin

L. Öhman, M. Simrén, M. Magnusson, 2019, Arthritis Research & Therapy.

High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T.

S. Larson, H. Lundqvist, J. Carlsson, 1999, Nuclear medicine and biology.

Mucosal and systemic immune profiles differ during early and late phase of the disease in patients with active ulcerative colitis.

L. Öhman, M. Simrén, M. Magnusson, 2019, Journal of Crohn's & colitis.

Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During Remission

L. Öhman, M. Magnusson, Otto Savolainen, 2021, Cellular and molecular gastroenterology and hepatology.

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms

L. Öhman, H. Törnblom, M. Simrén, 2020, Inflammatory bowel diseases.

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis

L. Öhman, D. Repsilber, M. D’Amato, 2022, Clinical and experimental gastroenterology.

CEG_A_368040 129..144

L. Öhman, D. Repsilber, M. D’Amato, 2022 .

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids

L. Öhman, H. Törnblom, M. Simrén, 2022, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation

J. Doré, J. Tap, L. Öhman, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients

A. Kumawat, R. Brummer, J. Sundin, 2014, Scandinavian journal of gastroenterology.

Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls

D. Repsilber, R. Brummer, J. Sundin, 2015, PloS one.

Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases

L. Öhman, M. Simrén, J. Sundin, 2017, Psychosomatic medicine.

The relationship between faecal‐associated and mucosal‐associated microbiota in irritable bowel syndrome patients and healthy subjects

W. M. Vos, D. Repsilber, S. Fuentes, 2015, Alimentary pharmacology & therapeutics.

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome

L. Öhman, L. Engstrand, H. Törnblom, 2020, Scientific Reports.

Altered faecal and mucosal microbial composition in post‐infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress

W. M. Vos, S. Fuentes, I. Heikamp-de Jong, 2015, Alimentary pharmacology & therapeutics.

Expression and Purification of Full-length CYP26 B1 and Spliced CYP26 B1

J. Sundin, 2009 .

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome

L. Öhman, H. Törnblom, M. Simrén, 2021, Cells.

A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome

J. Tap, L. Öhman, M. Cvijovic, 2021, Scientific reports.

Pharmacokinetics and red cell utilization of iron(III) hydroxide–sucrose complex in anaemic patients: a study using positron emission tomography

M. Lubberink, G. Antoni, B. Långström, 1999, British journal of haematology.

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease

L. Öhman, M. Simrén, M. Magnusson, 2020, BMC Gastroenterology.

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects

J. Doré, J. Tap, L. Öhman, 2018, Scientific Reports.

Kinetic analysis of 52Fe‐labelled iron(III) hydroxide–sucrose complex following bolus administration using positron emission tomography

M. Lubberink, G. Antoni, B. Långström, 1999, British journal of haematology.

[Woman in her 70s with rapidly increasing cognitive impairment].

H. Ihle-Hansen, J. Sundin, A. Øksengård, 2014, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome

L. Johnsen, L. Öhman, N. Juge, 2021, Nutrients.

The relationship between faecal‐associated and mucosal‐associated microbiota in irritable bowel syndrome patients and healthy subjects

D. Repsilber, S. Fuentes, R. Brummer, 2015, Alimentary pharmacology & therapeutics.